Cystobactamide: Topoisomerase-Inhibitoren aus Myxobakterien mit hoher antibakterieller Aktivität
- 15 December 2014
- journal article
- Published by Wiley in Angewandte Chemie
- Vol. 126 (52), 14835-14839
- https://doi.org/10.1002/ange.201409964
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Antibiotics from neglected bacterial sourcesInternational Journal of Medical Microbiology, 2014
- New strategies and compounds for anti-infective treatmentCurrent Opinion in Microbiology, 2013
- Aminobenzoates as building blocks for natural productassembly linesNatural Product Reports, 2011
- Myxobacterial secondary metabolites: bioactivities and modes-of-actionNatural Product Reports, 2010
- Nonribosomal peptide synthetases: structures and dynamicsCurrent Opinion in Structural Biology, 2010
- Antibiotics for Emerging PathogensScience, 2009
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative BacilliAntimicrobial Agents and Chemotherapy, 2008
- Drugs for bad bugs: confronting the challenges of antibacterial discoveryNature Reviews Drug Discovery, 2006
- The quinolones: decades of development and useJournal of Antimicrobial Chemotherapy, 2003